Jump to content

Mark J. Poznansky

Edit links
From Wikipedia, the free encyclopedia
Mark J. Poznansky
CM OOnt
Born (1946-04-25) April 25, 1946 (age 78)
Montreal, Quebec, Canada
Alma materMcGill University
Occupation(s)Scientist and Consultant
WebsiteG2G Consulting Website

Spindle Website

Saved By Science Website

Mark J. Poznansky CM OOnt (born April 25, 1946) is a research scientist, science administrator and science blogger. He is the past president and CEO of the Ontario Genomics Institute (OGI) and was previously chair of the board of OGI, and the founder of G2G Consulting Inc. He is a member of the Order of Canada, a member of the Order of Ontario and was CEO, president and scientific director of Robarts Research Institute.

Education and early career history

[edit]

Born in Montreal, Poznansky was educated at McGill University, receiving his PhD in Physiology in 1970. Poznansky completed his postdoctoral training in Biophysics at Harvard Medical School in 1972,[1] where he held the position of Lecturer in Biophysics until 1976. He also served as charge de recherche at the Collège de France in Paris from 1973 to 1974.

Poznansky returned to Canada in 1976, taking a position as associate professor of physiology at the University of Alberta in Edmonton.[2] Over the next 18 years, he rose to the rank of Professor and his laboratory developed an international reputation both the areas of cholesterol[3] and membrane biophysics[4] as well as enzyme replacement therapy[5] and the development of novel approaches to drug delivery.[6] In 1984, Poznansky moved on to become the associate dean of medicine at the University of Alberta in Edmonton, a position he held for 9 years.

Robarts Research Institute and the London years

[edit]

In 1993, Poznansky arrived in London, Ontario, as president and scientific director of Robarts Research Institute. He presided over a period of growth, not only in funding and employment but in technology transfer as well. Under his helm from 1993 until 2007, Robarts Research Institute increased its staff from just over 100 to over 600.[7] Annual research funding increased from $10 million per year to over $40 million annually and the Institute spun out 7 different companies including one that was sold to GE Healthcare.

While at Robarts, Poznansky served as president and CEO of London-based Viron Therapeutics Inc. The company was able to bring a candidate drug to the start of Phase II and raised $20 million to support future research efforts.

He was among a group that founded the London Biotechnology Incubator Inc.,[8] Ontario's first Life Sciences incubator. They were able to gain financial support to build a 50,000 sq. ft. facility in London.[9]

The rapid physical and staffing growth of the Institute led to major financial issues in 2007, necessitating the take-over of the Robarts by the University of Western Ontario. Poznansky stepped down as scientific director at that time.

G2G Consulting

[edit]

In 2008, Poznansky founded G2G Consulting Inc., services such as program reviews, mediation, strategic planning, change management, leadership training and mentoring and management restructuring.

Poznansky developed a process to help the Spanish government support the life sciences industry. He worked with the Canada Foundation for Innovation.[10]

He helped form a research partnership made up of Robarts Research Institute, Merck & Co, Merck Frosst Canada and GE Healthcare[11] that was able to receive funding of $20 million over four years, resulting in many key research findings and publications on the subject of lung disease. Poznansky helped change the way the University of Alberta, Edmonton conducted research and helped facilitate the amalgamation of the research administration that occurred when Ottawa Civic and Ottawa General Hospitals merged to create The Ottawa Hospital. He also aided the Thunder Bay Regional Institute in attracting not only some of the "most respected health research minds in Canada"[12] but those from around the globe.[13]

Poznansky completed the negotiation and advanced negotiation workshops at the Harvard Negotiation Institute, Harvard Law School.

Ontario Genomics Institute

[edit]

Poznansky was appointed as president and CEO of the Ontario Genomics Institute (OGI) on December 1, 2010.[14] He served in this capacity until August 1, 2017.[15] At OGI, Poznansky helped develop the Think Synthetic Biology campaign that identified the role that synthetic biology can play in advancing research for the wellbeing of Ontarians.[16]

Spindle

[edit]

On August 1, 2017, Poznansky joined Spindle, a strategic consulting firm that focuses on life and health sciences innovation, as a member of its Senior Advisory Group.[17]

Saved By Science Website

[edit]

In November 2019, Poznansky launched Saved By Science, a website at www.savedbyscience.org where he blogs on four subjects related to the world of science - the environment, food, health and politics/policy.[18] The website includes blogs on synthetic biology and climate change.

Saved By Science: The Hope and Promise of Synthetic Biology

[edit]

On September 22, 2020, ECW Press released Saved By Science: The Hope and Promise of Synthetic Biology.[19] Kirkus Reviews said the book was "energetic and optimistic" and “shows how synthetic biology can be used to contend with major issues involving health, food, and the environment."[19] An excerpt of Saved By Science: The Hope and Promise of Synthetic Biology appeared in the Toronto Star on September 19, 2020 [20] and in Canadian Geographic on September 23, 2020 [21] Dr. Poznansky was interviewed about the book on September 22, 2020 on SXM Canada Talks [22] and the Gill Deacon Show on the Canadian Broadcasting Corporation English radio network.

Chairs and board memberships

[edit]

Poznansky is Chair of Let's Talk Science,[23] Chief Science Advisor to the CEO of the Thunder Bay Regional Research Institute[24] and a board member of the Innovation Institute of Ontario.

Poznansky is a founding member and past Chair of the Council for Health Research in Canada,[25] a research advocacy group in Ottawa. He also chaired the Scientific Advisory Board of the Canadian Medical Discoveries Fund[8] and the board of MDS Capital Corp.[26]

He is a board member of the Consortium for the Barcode of Life.[27]

He has sat on the boards of organizations such as Diabetogen, BioMark Inc. and TechAlliance, London. Poznansky has also been a member of science-related committees including the Science Advisory Committee of the Heart and Stroke Foundation of Canada and the Medical Research Council of Canada Grants Panel.[28]

Guest lecturing

[edit]

Poznansky lectures on subjects related to the biopharmaceutical industry and research and administration and funding, including technology transfer. He also lectures on Jewish medical ethics as it pertains to human and animal experimentation.[29]

In 2017, Dr. Poznansky lectured on the Scientific Revolution at the Dr. Louis Siminovitch Lecture Series.[30]

He discussed Genomics Hype and Hope at the 2018 Notable Speakers Series held in Toronto.[31]

Dr. Poznansky presented at a session at the 2019 Canadian Science Conference on: Policy Lessons in the Age of Technological Disruption.[32]

Other accomplishments

[edit]

In 2005, Poznansky was made a member of the Order of Canada[33] and a member of the Order of Ontario.[34] He is also the recipient of the Queen Elizabeth II Golden Jubilee Medal.[8]

Poznansky led the development of the book Using Our Heads, "a celebration of innovation that was supported by the Ontario Innovation Trust (OIT)."[35]

He is one of the founders of the Canadian Medical Hall of Fame, and served on its board of directors from 1994 to 2001.[36]

Other books

[edit]

References

[edit]
  1. ^ "Board of Directors". www.ontariogenomics.ca. Archived from the original on September 5, 2012.
  2. ^ "Press release on Mark Poznansky by Thunder Bay Regional Research Institute that presents biographical information including a discussion of his stints at University of Alberta and Harvard" (PDF). Archived from the original (PDF) on 2011-07-16. Retrieved 2009-11-17.
  3. ^ Poznansky, Mark; Lange, Yvonne (February 28, 1976). "Transbilayer movement of cholesterol in dipalmitoyllecithin–cholesterol vesicles". Nature. 259 (5542): 420–422. Bibcode:1976Natur.259..420P. doi:10.1038/259420a0. PMID 1250389. S2CID 9321598 – via www.nature.com.
  4. ^ Regulation of human red cell volume by linked cation fluxes published in Journal of Membrane Biology, Volume 10, Number 1/December, 1972, Page 259-266
  5. ^ Enzyme-Albumin Polymers: New Approaches to the Use of Enzymes in Medicine published in Artificial Cells, Blood Substitutes, and Biotechnology, Volume 15, Issue 4 January 1987, Pages 751 - 774
  6. ^ Thomas, Panakkezhum D.; Poznansky, Mark J. (1990). "A modified tetramethylbenzidine method for measuring lipid hydroperoxides". Analytical Biochemistry. 188 (1): 228–232. doi:10.1016/0003-2697(90)90557-P. PMID 2221366.
  7. ^ "Bioportfolio on Robarts Research Institute". Archived from the original on 2010-04-11. Retrieved 2009-11-06.
  8. ^ a b c "Robarts president awarded Queens Golden Jubi".
  9. ^ University of Western Ontario press release
  10. ^ "Link provided on web page to download list of participants where Poznansky is listed". www.innovation.ca.
  11. ^ "Canada's most powerful MRI device installed in London".
  12. ^ Home page from TBRI
  13. ^ Regional Bioscience Spotlight: Thunder Bay.
  14. ^ "Dr. Mark J. Poznansky Appointed as President and CEO of the Ontario Genomics Institute | Ontario Genomics Institute". Archived from the original on 2011-10-04. Retrieved 2011-04-25.
  15. ^ "Stocks". Bloomberg News. 20 June 2023.
  16. ^ http://www.ontariogenomics.ca/syntheticbiology/Ontario_Synthetic_Biology_Report_2016.pdf [bare URL PDF]
  17. ^ "Our Team - Spindle Strategy". 17 May 2022.
  18. ^ "Blog". www.savedbyscience.org.
  19. ^ a b "SAVED BY SCIENCE". www.kirkusreviews.com.
  20. ^ "Mark J. Poznansky, author of new book 'Saved by Science,' says synthetic biology may be the hope for mankind's future | The Star". Toronto Star. 19 September 2020.
  21. ^ "Excerpt from Saved by Science: The Hope and Promise of Synthetic Biology".
  22. ^ @CanadaTalks167 (September 22, 2020). ". @TheBreakdown167 w/ @allisondore & @Cassandra___B is LIVE from 2-4pmET! Today @JudyPenzSheluk on @crimewriterscan Awards of Excellence & this months releases; @raffpylon on his single 'King's Lane' & @amnesty fundraiser; plus we'll talk to Dr. Mark J. Poznansky @saved_byscience" (Tweet) – via Twitter.
  23. ^ "Board listing of Let's Talk Science".
  24. ^ "Article on Dr. Mark Poznansky joining the Thunder Bay Regional Research Institute". Archived from the original on 2011-07-24. Retrieved 2009-11-17.
  25. ^ "Evidence - FINA (36-1) - No. 28 - House of Commons of Canada". www.ourcommons.ca.
  26. ^ "McGill announcement". Archived from the original on 2011-05-15. Retrieved 2017-09-04.
  27. ^ "Mark Poznansky - iBOL Board Member". ibol.org.
  28. ^ Dr. Mark Poznansky Executive Profile at BusinessWeek.
  29. ^ Jewish ethics viewed as helpful in medicine by Mara Koven, published in The Canadian Jewish News February 3, 1994, Page 20
  30. ^ "The Scientific Revolution with Dr. Mark Poznansky | UJA Federation of Greater Toronto". jewishtoronto.com.
  31. ^ "Notable Speakers Series: Dr. Mark J. Poznansky on Apr 16th 2018 1:00pm". www.beth-tzedec.org.
  32. ^ "CSPC 2019 Schedule". cspc2019.sched.com.
  33. ^ "Article on Order of Canada appointments being announced". Archived from the original on December 18, 2005.
  34. ^ "Article on Dr. Mark J. Poznansky being appointed a member of the Order of Ontario". Archived from the original on 2011-05-15. Retrieved 2017-09-04.
  35. ^ "The people behind Using Our Heads". Archived from the original on 2010-04-25. Retrieved 2009-11-07.
  36. ^ https://www.cdnmedhall.org/sites/default/files/history_of_cmhf_-_final.pdf [bare URL PDF]
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mark_J._Poznansky&oldid=1248569382"